ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01692470
Recruitment Status : Withdrawn (The company decided to cancel this study in conformity with Philippines FDA Circular 2013-004)
First Posted : September 25, 2012
Last Update Posted : December 2, 2015
Sponsor:
Information provided by (Responsible Party):
Janssen Pharmaceutica

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2015
  Estimated Study Completion Date : December 2015